July 6, 2018
The Trump administration proposed to change the FDA’s name to the Federal Drug Administration and shift the agency’s food programs to the U.S. Department of Agriculture. […]
July 6, 2018
Purdue Pharma, which manufactures OxyContin, laid off its entire sales force, ending an era for the drug that became synonymous with the nation’s opioid crisis. […]
August 10, 2018
The FDA used a new pathway aimed at speeding review for generics of products without competition for the first time by approving Apotex’s oral solution of […]
August 16, 2018
It’s that time of year when Express Scripts releases its new list of formulary exclusions. For 2019, the PBM barred 48 drugs from its national preferred […]
August 17, 2018
The FDA granted the first U.S. approval of a drug that works by “silencing” genes to stop disease. Alnylam Pharmaceuticals’ drug, Onpattro, stems from Nobel Prize-winning […]
August 17, 2018
Spark Therapeutics’ experimental gene therapy, SPK-8011, sharply lowered the number of bleeds in a dozen patients with hemophilia A, prompting the company to push forward into […]
August 17, 2018
Pfizer CEO Ian Read believes the U.S. will eventually have a system without drug rebates, especially considering the Trump administration’s proposed plan to restrict these kickback […]
August 17, 2018
Leonard Schleifer, cofounder of Regeneron Pharmaceuticals, criticizes the pricing practices of other drug companies. But Regeneron, like other biotech firms, spends huge sums to find new […]
September 28, 2018
Moderna Therapeutics, a biotech valued at over $7.5B, is preparing for an initial public offering that could come as early as this winter. The company, based […]